Judge Orders Redo In First AbbVie Testosterone MDL Trial
Law360 (February 26, 2018, 4:44 PM EST) -- An Illinois federal judge has ordered a new trial in the first bellwether against AbbVie Inc. in the multidistrict litigation over testosterone replacement therapy products after finding that the jury likely misunderstood the issue of causation.
After reconsidering an earlier decision to order a new trial on just one of plaintiff Jesse Mitchell's claims, U.S. District Judge Matthew Kennelly on Saturday said that he wants the whole of Mitchell's case retried next month. The jury's verdict on Mitchell's three claims, handed down in July, was inconsistent and must be thrown out, Judge Kennelly said.
Mitchell sued AbbVie in 2014 after he...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!